Dr. Yvonne Myal, professor of pathology and a senior scientist at CancerCare Research Institute, has been awarded five-year funding by NSERC for her research project titled Delineating the Multifunctional Role of the Mouse Submandibular Gland Protein (mSMGP).
Dr. Tanveer Sharif, assistant professor of pathology, has been awarded five-year funding by NSERC for his research project titled Understanding the role of pyruvate metabolism-dependent signaling networks in the differentiation of neural stem cells.
Dr. Jason Kindrachuk, assistant professor of medical microbiology and infectious diseases, received more than $725,000 in funding from a CIHR Fall 2020 – Project Grant for his research project titled Identification of the molecular determinants underlying asymptomatic Ebola virus testicular infections and long-term effects on reproductive heal.
Dr. Lyle McKinnon, associate professor of medical microbiology and infectious diseases, received $100,000 in funding from CIHR Fall 2020 – Bridge Funding for his research project titled Regulatory T cells and the control of female genital inflammation: relevance for HIV prevention. Dr. McKinnon also received $250,000 in funding from the New Frontiers in Research Fund – Exploration for his research project titled Contextualizing the ethical implications of HIV molecular epidemiology: a critical knowledge exchange project.
Dr. George Zhanel, professor of medical microbiology and infectious diseases, received more than $160,000 in funding from Merck Canada for his research project titled Predicting PCV15 and PPV23 Coverage for Prevention of BOTH Invasive Pneumococcal Disease-(IPD) and Community Acquired Pneumonia-(CAP) in Patients Across Canada: PCV15 and PPV23 Coverage of 2,000 Respiratory Tract Infection and 1,000 Invasive Isolates of Streptococcus pneumoniae (Including Antibiotic Resistant and Multi-Drug Resistant-MDR Strains) Over 2007-2018 using the CANWARD Study. Also from Merck Canada, Dr. Zhanel received more than $475,000 in funding for his research project titled In Vitro Activity of Ceftolozane/Tazobactam, Imipenem/Relebactam, Ertapenem, Tedizolid and Comparators in the CANWARD 2017-2022 Study. He received $20,000 in funding from Avir Pharma Inc. for his research project titled Management and Analysis of the CLEAR (Canadian LEadership on Antimicrobial Real-life Usage) Registry. He also received $51,500 funding from Shionogi & Co. Ltd for his research project titled Activity of Cefiderocol Against 1,000 Ceftazidime-nonsusceptible (NonS), Ciprofloxacin-NonS, Colistin-NonS, Meropenem-NonS, Amikacin-NonS, Piperacillin/tazobactam-NonS, Ceftolozane/tazobactam-NonS, Ceftazidime/avibactam-NonS, Multidrug-resistant (MDR) and Extensively Drug-resistant (XDR) Pseudomonas aeruginosa Collected from the CANWARD 2007-2018 Study.
Dr. Stephanie Booth, assistant professor of medical microbiology and infectious diseases, received $63,000 in funding from the CJD Foundation for her research project titled Detection and characterization of rare strains of sporadic Creutzfeldt-Jakob Disease using a suite of novel biological and biochemical too.
Afifi, T.O., Sareen, J., Enns, M.W., Carleton, R. N., Mota, N., Bolton, S-L, Taillieu, T., Van Til, L., & Heber. A. Cannabis and mental health among veterans in Canada: Understanding the role of trauma and impact on help-seeking. Canadian Institutes of Health Research (CIHR). Catalyst Grant. 2021-2022. $114,746.